How to Arm Yourself for the Upcoming Battle: The New Frontier of Pharma and Medical Device Marketing

You May Like These Articles

  • Recent
  • Featured
  • Related

How to Find Product-Market Fit by Going Deep Versus Wide: Interview with New View Surgical CEO Bryce Klontz

New View Surgical CEO Bryce Klontz shares insights from his decades of experience in the surgical devices space, from building relationships of trust with regulators and investors to working closely with practitioners to perfect product-market fit.

Turning Your End Users Into Key Investors: Interview with Lazurite CEO and Co-founder Eugene Malinskiy

Lazurite CEO Eugene Malinskiy shares how planning out every step of ArthroFree’s regulatory strategy helped streamline the FDA clearance process, the importance of preparing for failure, and why entrepreneurs should seek out input from investors at every step of the process.

How to Build a Strong Network of Investors and Partners for Your Medtech Startup: Interview with DermaSensor CEO Cody Simmons

DermaSensor CEO Cody Simmons shares why he thinks companies need to focus on regulatory and reimbursement alignment from the very beginning, the importance of finding ally investors, and how to build trust with potential partners in your network.

Why Your Product Should Generate Revenue Versus Reduce Costs: Interview with Cognetivity CEO Sina Habibi

Cognetivity Neurosciences Co-founder and CEO Sina Habibi discusses the importance of collaborating with regulators and end users, why he primarily focuses on the value of revenue generation versus cost savings, and the benefits of teaming up with an expert fundraiser.

Conquering the Coverage and Reimbursement Landscape: Interview with Bruce Shook, President of Intact Vascular

In this interview, Bruce Shook discusses medical device insurance coverage and reimbursement, as well as advice for other healthcare entrepreneurs that need to raise money.

Why Curiosity and Persistence are Crucial Characteristics for Medtech Entrepreneurs: Interview with the Legendary Dr. John Simpson, Executive Chairman of Avinger

In this interview, the legendary Dr. John Simpson shares what drew him to the field of cardiology, his approach to building a medtech team, and why knowing your strengths and limitations is key to making a difference in the lives of others.

After Selling 2 Cardiovascular Companies for Over $1 Billion, Duke Rohlen is Now Hoping to do the Same with Spirox and Advanced Cardiac Therapeutics

In this interview with Duke Rohen, he discusses how he successfully led two early-stage medtech companies at the same time and the major lessons he learned raising money for 4 different medical device companies.

Having a Heart Attack? There’s an App for That! The Incredible Story of How Dr. David Albert Brought the ECG iPhone App to Market

In this interview with Dr. David Albert, we learn about his incredible journey in bringing the first iPhone ECG app to market with AliveCor.

Patient Engagement for Medtech Companies is Hard: Here’s Some Advice on How to Do it Right

In this interview, Neal Sofian, explains how to overcome some of the legal challenges associated with patient interactions and two things that medical device companies should do right now to improve their patient engagement initiatives.

Inside the Mind of a Medtech VP of Sales: Interview with Sean Moore

In this interview with medtech sales and marketing expert Sean Moore, he reveals the top 3-5 keys to his rapid career advancement within the medtech space and the character traits of the most successful medical devices sales reps and managers.

Why Medtech Companies Should Care More About Sales Operations: Interview with Andrea Traverso

In this interview with Andrea Traverso, she explains which business intelligence platforms medtech companies should be using.

4 Can’t-Miss Opportunities That All Medtech Companies Need to Consider: Interview with Jonas Funk

In this interview with veteran medtech consultant, Jonas Funk, he explains the 4 critical questions that medical device companies need to answer right now.